top of page


Upcoming clinical trial: The effect of Rebox current in pain management

In September 2023, a clinical trial "The effect of Rebox current in pain management" will start at F.D. Roosevelt University Hospital in Banská Bystrica, Slovakia. This post-marketing monocentric double-blind sham controlled crossover study will assess the efficacy of Rebox electrotherapy in the treatment of pain. Totally 72 patients will be treated with both real and sham Rebox device in a crossover design with a 1:1 ratio over a 6-week period. The degree of pain intensity reduction after the real Rebox stimulation will be evaluated in comparison with the sham stimulation. Moreover, differences in multidimensional aspects of pain will be compared between the real and sham stimulation. For more details, see

Cooperation with Biomed Neurotechnologie

We are happy to announce the start of cooperation with Biomed Neurotechnologie. Since 2007, Biomed has been popularizing the latest achievements in the field of neuromodulation, neuropsychology, psychophysiology and pedagogy in Poland.


New Rebox-Physio 4 and Rebox-Physio tDCS models

We proudly introduce new CE-certified models for the European market. Learn more about Rebox-Physio 4 and Rebox-Physio tDCS for Transcranial Direct Current Stimulation.


COVID-19 pandemics situation

Despite currently severe situation due to COVID-19 pandemics in the Czech Republic, our production, service and research activities remain unaffected.


Rebox Therapy in Medical Biophysics textbook

Rebox therapy method has been included in 2nd edition of Czech Medical Biophysics textbook for general medicine students. The book can be purchased here.

bottom of page